Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Health-Related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: Results From a Phase II Randomized TrialEur Urol 2018 Dec 24;[EPub Ahead of Print], DJ Khalaf, K Sunderland, BJ Eigl, CK Kollmannsberger, N Ivanov, DL Finch, C Oja, J Vergidis, M Zulfiqar, ME Gleave, KN Chi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.